More about prostate cancer--expectant management versus treatment
Anscher, M.S.
North Carolina Medical Journal 60(6): 313-314
1999
ISSN/ISBN: 0029-2559 PMID: 10581934 Document Number: 503064
Document emailed within 1 workday
Related Documents
O'Rourke, M.E. 2008: Expectant management as a treatment for early-stage prostate cancer Oncology 22(2 Suppl Nurse Ed): 36-38Klotz, L.H.; Choo, R.; Morton, G.; Danjoux, C. 2002: Expectant management with selective delayed intervention for favorable-risk prostate cancer Canadian Journal of Urology 9(Suppl 1): 2-7
Kamoto, T. 2002: Management of side effects of endocrine treatment for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 299-303
Yurac, M.; Balandrón, M.; Vaccaro, H.; Vinagre, M.; Roncone, E. 1992: The treatment of ectopic pregnancy with local and intramuscular methotrexate or expectant management Revista Chilena de Obstetricia y Ginecologia 57(4): 263-272
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Habib, F.K.; Ross, M.; Bayne, C.W. 1999: Factors controlling the expression of 5alpha-reductase in human prostate: A possible new approach for the treatment of prostate cancer European Urology 35(5-6): 439-442
Kumar, M.; Meena, J.; Gupta, U.; Singh, A.; Jain, N. 2011: Management of early onset severe preeclampsia in a tertiary hospital in India: does expectant management alter perinatal outcome? Indian Journal of Medical Sciences 65(12): 535-542
Bonnal, J.-L.; Irani, J.; Maidenberg, M.; Théodore, C.; Mauroy, B. 2003: Management of bladder cancer associated with prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(6): 1286-1289
Glicksman, A.S. 2006: Radiation management of prostate cancer Medicine and Health Rhode Island 89(2): 74-75
Fournier, G. 1994: Management of advanced prostate cancer La Revue du Praticien 44(5): 595-600
Sim, H.Gee.; Lim, K.H.C.; Tay, M.Hiang.; Chong, K.Tai.; Chiong, E. 2013: Guidelines on management of prostate cancer Annals of the Academy of Medicine Singapore 42(4): 190-199
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Pierotic, M.; Silva, S.; Rojas, I.; Henríquez, R.; Poblete, A. 1994: Expectant management of missed abortion Revista Chilena de Obstetricia y Ginecologia 59(2): 73-77; Discussion: 77-78
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Trachtenberg, J. 1994: State-of-the-art hormonal management of prostate cancer Canadian Journal of Urology 1(3): 49-52
Bernier, J. 2007: The role of radiotherapy in the management of prostate cancer Revue Medicale Suisse 3(114): 1472-1474
Gross, J.S. 1990: Current management modalities for prostate cancer Geriatrics 45(4): 60
Gibbons, R.P. 1989: Management of hormone-resistant prostate cancer Progress in Clinical and Biological Research 303: 337-345